Lee Ainslie Axonics, Inc. Transaction History

Maverick Capital LTD

  • $5.07 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$47.99 - $60.21 $459,456 - $576,450
-9,574 Reduced 54.62%
7,953 $401,000
Q1 2023

May 15, 2023
BUY
$52.6 - $67.34 $342,215 - $438,114
6,506 Added 59.03%
17,527 $956,000
Q4 2022

Feb 14, 2023
BUY
$59.56 - $76.6 $656,410 - $844,208
11,021 New
11,021 $689,000

Others Institutions Holding AXNX

# of Institutions
235
Shares Held
42.8M
Call Options Held
73.7K
Put Options Held
230K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.45B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email